Découvrez les Meilleures Cliniques et Coûts pour Votre Thérapie au lutétium-177 aux États-Unis en 2026

This protocol strategically uses 4 treatment courses spaced 6 weeks apart to optimize PSMA-targeted cancer response. Professor Cuneyt Turkmen, with 900+ Lutetium-177 procedures performed, leads treatment at the JCI-accredited Memorial Şişli Hospital. The cost is about $7,000 per course, covering the 1-day nuclear medicine ward hospitalization and consultation. It includes a required pre-therapy Ga-68 PET-CT, post-treatment whole-body scintigraphy, and follow-up blood tests at 2 and 4 weeks. Complimentary Russian translation and VIP transfers facilitate international care.

This package follows American standards through its affiliation with Johns Hopkins Medicine at the JCI-accredited Anadolu Medical Center. Dr. Kezban Berberoglu leads the evaluation and administration in a structured 4-day cycle: diagnostics on day two, Lu-177 PSMA therapy on day three, and a post-treatment scan on day four. The total cost is approximately $10,370, covering the therapy and associated medical supervision. Patients receive comprehensive support with free airport transfers, interpreters, and a medical second opinion to streamline their international care journey.

This LUTETHIUM THERAPY package targets PSMA-positive cancer with a dose capacity up to 200 mCi of Lutetium-177. Associate Professor Tamer Aksoy, a nuclear medicine specialist with 25+ years of experience and clinical research at the Netherlands Cancer Institute, delivers the treatment. It involves a planned protocol of 6–8 sessions at Hisar Hospital Intercontinental. Costs are approximately $8,800, which includes each therapy session, VIP transfers, a personal assistant, and translation services. The JCI-accredited Nuclear Medicine department provides PET/CT imaging validation for treatment planning.